Back to Search
Start Over
The British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritis
- Source :
- Humphreys, J 2019, ' The British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritis. ', Rheumatology (Oxford), vol. 58, no. 2, pp. e3-e42 . https://doi.org/10.1093/rheumatology/key208
- Publication Year :
- 2019
-
Abstract
- The use of biologic therapies has transformed the management of inflammatory arthritis (IA). In contrast to conventional systemic DMARDs (csDMARDs) traditionally used to treat inflammatory disease, these agents offer a targeted approach, and their widespread use has resulted in disease remission becoming an increasingly achievable goal. Biologic therapies are not without potential risk, and hence it is important that clinicians are aware of these risks and ensure that appropriate precautions are taken to minimize them. Information on the safety of biologic therapies continues to be collected through national registries, clinical and cohort studies and case series and reports.NICE has accredited the process used by the BSR to produce its guidance on the safety of biologic DMARDs in inflammatory arthritis. Accreditation is valid for 5 years from 10 June 2013This guideline supersedes the previous BSR/BHPR anti-TNF [1], rituximab (RTX) [2] and tocilizumab (TCZ) [3] guidelines and has been developed in line with the BSR Guidelines Protocol.
- Subjects :
- rheumatoid arthritis
safety
medicine.medical_specialty
Heart Diseases
Tumor necrosis factors
Inflammatory arthritis
MEDLINE
Arthritis
HIV Infections
Comorbidity
Opportunistic Infections
Arthritis, Rheumatoid
03 medical and health sciences
0302 clinical medicine
Rheumatology
Neoplasms
Internal medicine
ankylosing spondylitis
medicine
Humans
Tuberculosis
Pharmacology (medical)
030212 general & internal medicine
030203 arthritis & rheumatology
psoriatic arthritis
Biological Products
Evidence-Based Medicine
business.industry
Arthritis, Psoriatic
Vaccination
Contraindications, Drug
anti-TNF
Respiration Disorders
medicine.disease
Safety guidelines
Antirheumatic Agents
Biologic DMARD
Patient Safety
business
biologic
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Journal :
- Humphreys, J 2019, ' The British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritis. ', Rheumatology (Oxford), vol. 58, no. 2, pp. e3-e42 . https://doi.org/10.1093/rheumatology/key208
- Accession number :
- edsair.doi.dedup.....fc98c60df1bcae57f8c41009bb24cc51